middle.news
How Will Recce’s A$30M Debt Facility Accelerate Its Fight Against Superbugs?
11:01am on Tuesday 17th of June, 2025 AEST
•
Healthcare
Read Story
How Will Recce’s A$30M Debt Facility Accelerate Its Fight Against Superbugs?
11:01am on Tuesday 17th of June, 2025 AEST
Key Points
A$30 million debt facility established with Avenue Capital Group
Initial A$11.5 million non-dilutive funding drawn to support Phase 3 trials
Pro-forma cash position strengthened to A$27.5 million plus expected A$8.5 million R&D rebate
Facility secured against all assets including intellectual property
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Recce Pharmaceuticals (ASX:RCE)
OPEN ARTICLE